c-Jun NH2-terminal Kinase-mediated Activation of Interleukin-1β Converting Enzyme/CED-3-like Protease during Anticancer Drug-induced ApoptosisHiroyuki Seimiya, Takashi Tsuruo|Journal of Biological Chemistry|1997Cited by 205
Acyl‐CoA synthetase as a cancer survival factor: its inhibition enhances the efficacy of etoposideTetsuo Mashima, Hiroyuki Seimiya|Cancer Science|2009Cited by 90
<scp>RK</scp>‐287107, a potent and specific tankyrase inhibitor, blocks colorectal cancer cell growth in a preclinical modelAnna Mizutani, Hiroyuki Seimiya|Cancer Science|2018Cited by 78
ALDH1A3‐mTOR axis as a therapeutic target for anticancer drug‐tolerant persister cells in gastric cancerRyuhei Kawakami, Hiroyuki Seimiya|Cancer Science|2020Cited by 67
Inhibition of ATP Citrate Lyase Induces an Anticancer Effect via Reactive Oxygen SpeciesToshiro Migita, Hiroyuki Seimiya|American Journal Of Pathology|2013Cited by 56